Record Q1 Confirms Growth, but Premium Valuation Demands Proof

What happened

Aura Minerals posted a record Q1 2026, with revenue and EBITDA up sharply as GEO output rose 37% year over year, driven by the Borborema ramp and MSG gains. While the operational momentum validates the company's growth narrative, the stock's 12.5x EV/EBITDA leaves little room for error. The DeepValue report rates AUGO a WAIT, noting that the premium pricing assumes flawless execution across Borborema, MSG, and Era Dorada—a high bar. Q1 results alone do not resolve the key risks: MSG must show sustainable cost improvement, and Borborema must maintain recovery levels and deliver on expansion milestones. Until these proofs materialize in subsequent quarters, the current valuation offers insufficient margin of safety.

Implication

The record Q1 2026 confirms that Aura can deliver on volume growth, but the 12.5x EV/EBITDA already prices in continued success. The main worry remains the 2026 AISC guidance of $1,720–$1,865, driven by MSG's turnaround—Q1 data did not yet prove this cost trajectory is under control. Borborema's improved recovery must hold, and the road-relocation and water-access milestones must appear with firm dates. Furthermore, Era Dorada construction progress remains an unknown that could strain capex if delays emerge. Consequently, the prudent stance is to hold or trim at current levels, looking for a better entry around $70 or until three consecutive quarters of cost and output confirm the bull case.

Thesis delta

The Q1 2026 results reduce some near-term operational risk by showing strong output, but they do not change the fundamental thesis that AUGO is a wait at current prices. The premium valuation still requires two observable proofs: MSG cost improvement by H2 2026 and dated Borborema expansion milestones. Until those materialize, the stock remains priced for perfection with limited downside protection.